...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

** Apabetalone (RVX-208) Currently Being Tested in a Phase 3 BETonMACE Cardiovascular Outcomes Trial ** BETonMACE Trial is Fully Enrolled and Top-Line Data Expected Mid-Year 2019 https://clinicaltrials.gov/ct2/show/NCT02586155

Message: I would have thought we'd see more volume....

"Maybe it’ll retrace to the $2.80 to $3.20 range before coming back to new highs."

Better than Chesspoker's $2.28 retracement prediction from a month ago! If one keeps guessing long enough, one is bound to get it right one of these times!

New Message
Please login to post a reply